Diabetes Drug Spending Tripled Between 2002-2013: The Data Behind Rising Costs
How Much Did Diabetes Drug Spending Increase Between 2002 and 2013?
U.S. expenditures on antihyperglycemic medications skyrocketed from $6.7 billion in 2002 to $22.3 billion in 2013 - a 233% increase that far exceeded inflation, population growth, or diabetes prevalence changes. Insulin accounted for the largest portion of this spending growth, with costs rising from $1.2 billion to $6.0 billion during the same period, representing a 400% increase that transformed diabetes treatment from affordable to financially devastating for many patients.